Cost of integrated chronic care for severe non-communicable diseases at district hospitals in rural Rwanda.
cost-analysis
integrated delivery of health care
noncommunicable diseases
sub-saharan africa
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
01
2019
revised:
29
04
2019
accepted:
04
05
2019
entrez:
20
7
2019
pubmed:
20
7
2019
medline:
20
7
2019
Statut:
epublish
Résumé
Integrated clinical strategies to address non-communicable disease (NCDs) in sub-Saharan Africa have largely been directed to prevention and treatment of common conditions at primary health centres. This study examines the cost of organising integrated nurse-driven, physician-supervised chronic care for more severe NCDs at an outpatient specialty clinic associated with a district hospital in rural Rwanda. Conditions addressed included type 1 and type 2 diabetes, chronic respiratory disease, heart failure and rheumatic heart disease. A retrospective costing analysis was conducted from the facility perspective using data from administrative sources and the electronic medical record systems of Butaro District Hospital in rural Rwanda. We determined initial start-up and annual operating financial cost of the Butaro district advanced NCD clinic for the fiscal year 2013-2014. Per-patient annual cost by disease category was determined. A total of US$47 976 in fixed start-up costs was necessary to establish a new advanced NCD clinic serving a population of approximately 300 000 people (US$0.16 per capita). The additional annual operating cost for this clinic was US$68 975 (US$0.23 per capita) to manage a 632-patient cohort and provide training, supervision and mentorship to primary health centres. Labour comprised 54% of total cost, followed by medications at 17%. Diabetes mellitus had the highest annual cost per patient (US$151), followed by heart failure (US$104), driven primarily by medication therapy and laboratory testing. This is the first study to evaluate the costs of integrated, decentralised chronic care for some severe NCDs in rural sub-Saharan Africa. The findings show that these services may be affordable to governments even in the most constrained health systems.
Sections du résumé
BACKGROUND
BACKGROUND
Integrated clinical strategies to address non-communicable disease (NCDs) in sub-Saharan Africa have largely been directed to prevention and treatment of common conditions at primary health centres. This study examines the cost of organising integrated nurse-driven, physician-supervised chronic care for more severe NCDs at an outpatient specialty clinic associated with a district hospital in rural Rwanda. Conditions addressed included type 1 and type 2 diabetes, chronic respiratory disease, heart failure and rheumatic heart disease.
METHODS
METHODS
A retrospective costing analysis was conducted from the facility perspective using data from administrative sources and the electronic medical record systems of Butaro District Hospital in rural Rwanda. We determined initial start-up and annual operating financial cost of the Butaro district advanced NCD clinic for the fiscal year 2013-2014. Per-patient annual cost by disease category was determined.
RESULTS
RESULTS
A total of US$47 976 in fixed start-up costs was necessary to establish a new advanced NCD clinic serving a population of approximately 300 000 people (US$0.16 per capita). The additional annual operating cost for this clinic was US$68 975 (US$0.23 per capita) to manage a 632-patient cohort and provide training, supervision and mentorship to primary health centres. Labour comprised 54% of total cost, followed by medications at 17%. Diabetes mellitus had the highest annual cost per patient (US$151), followed by heart failure (US$104), driven primarily by medication therapy and laboratory testing.
CONCLUSIONS
CONCLUSIONS
This is the first study to evaluate the costs of integrated, decentralised chronic care for some severe NCDs in rural sub-Saharan Africa. The findings show that these services may be affordable to governments even in the most constrained health systems.
Identifiants
pubmed: 31321086
doi: 10.1136/bmjgh-2019-001449
pii: bmjgh-2019-001449
pmc: PMC6597643
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e001449Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet. 2003 Mar 1;361(9359):717-25
pubmed: 12620735
Trials. 2011 Jan 05;12:3
pubmed: 21205325
JACC Heart Fail. 2013 Jun;1(3):230-6
pubmed: 24621875
Bull World Health Organ. 2014 Jun 1;92(6):389
pubmed: 24940009
Lancet Diabetes Endocrinol. 2015 Jun;3(6):402-403
pubmed: 26003752
Lancet. 2015 Sep 26;386(10000):1221-1222
pubmed: 26403914
Healthc (Amst). 2015 Dec;3(4):215-20
pubmed: 26699346
Heart. 2017 Dec;103(23):1874-1879
pubmed: 28490619
Lancet Glob Health. 2017 Sep;5(9):e875-e887
pubmed: 28728918
Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1176-1182
pubmed: 28766486
J Diabetes Res. 2017;2017:2657820
pubmed: 29362719
Lancet. 2018 May 19;391(10134):2071-2078
pubmed: 29627159
Heart. 2018 Oct;104(20):1707-1713
pubmed: 29678896
Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004881
pubmed: 30562070
J Am Coll Cardiol. 2019 Mar 5;73(8):977-980
pubmed: 30819366